<DOC>
	<DOCNO>NCT00141375</DOCNO>
	<brief_summary>To evaluate long-term safety efficacy pregabalin treatment neuropathic pain spinal cord injury .</brief_summary>
	<brief_title>To Evaluate Long-Term Safety Efficacy Pregabalin Treatment Neuropathic Pain After Spinal Cord Injury .</brief_title>
	<detailed_description />
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Must meet inclusion criterion precede doubleblind BID study central pain follow spinal cord injury . Must receive study medication doubleblind condition . Patients participate experience serious adverse event previous doubleblind BID study determine related study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>